APA (7th ed.) Citation

GL, C., A, D., S, D. M., H, O., & GM, B. (2025). Health and Economic Advantages Associated With the Use of TachoSil: An Update of Systematic Review. Therapeutics and clinical risk management, 21, 257. https://doi.org/10.2147/TCRM.S476650

Chicago Style (17th ed.) Citation

GL, Colombo, Droghetti A, Di Matteo S, Ottenjann H, and Bruno GM. "Health and Economic Advantages Associated With the Use of TachoSil: An Update of Systematic Review." Therapeutics and Clinical Risk Management 21 (2025): 257. https://doi.org/10.2147/TCRM.S476650.

MLA (9th ed.) Citation

GL, Colombo, et al. "Health and Economic Advantages Associated With the Use of TachoSil: An Update of Systematic Review." Therapeutics and Clinical Risk Management, vol. 21, 2025, p. 257, https://doi.org/10.2147/TCRM.S476650.